Page 291 - Feline Cardiology

298 Section G: Congestive Heart Failure

large-scale studies of cats with CHF secondary Besarab A, Bolton WK, Browne JK, Egrie JC, Nissenson AR, Okamoto
to HCM were highly disparate and ranged from 92–563 DM, et al. The effects of normal as compared with low hematocrit
days (Rush et al. 2002; Atkins et al. 1992). Similarly, values in patients with cardiac disease who are receiving hemodi-
alysis and epoetin. N Engl J Med 1998;339:584–590.
there are contradicting results regarding negative Bettencourt P, Ferreira S, Azevedo A, Ferreira A. Preliminary data on
predictors for survival in cats with HCM and heart the potential usefulness of B-type natriuretic peptide levels in
failure. One study found that survival was not influ- predicting outcome after hospital discharge in patients with heart
enced by the age at onset, sex, body weight, or breed, but failure. Am J Med 2002;113:215–219.
tachycardia (>200 bpm) at presentation was a negative Biondo AW, Ehrhart EJ, Sisson DD, Bulmer BJ, De Morais HS, Solter
prognostic indicator (Atkins et al. 1992). In contrast, PF. Immunohistochemistry of atrial and brain natriuretic peptides
in control cats and cats with hypertrophic cardiomyopathy. Vet
another study found that left atrial size and increased Pathol 2003;40:501–506.
age were independent negative prognostic indicators Boswood A, Murphy A. The effect of heart disease, heart failure and
(Rush et al. 2002). Cats that have an identifiable precipi- diuresis on selected laboratory and electrocardiographic parame-
tating factor—such as long-acting corticosteroid admin- ters in dogs. J Vet Cardiol 2006;8:1–9.
istration, surgery, fluid administration, or a stressful Boswood A, Dukes-McEwan J, Loureiro J, James RA, Martin M,
Stafford-Johnson M, et al. The diagnostic accuracy of different
tachycardic event (e.g., being chased by a dog)—tend to natriuretic peptides in the investigation of canine cardiac disease.
live longer than cats with severe HCM and severe left Brater DC. Diuretic therapy. N Engl J Med 1998;339:387–395.
J Small Anim Pract 2008;49:26–32.
atrial dilation that develop heart failure without a pre-
Congestive Heart Failure important marker for severity of disease in people with Brilla CG, Zhou G, Matsubara L, Weber KT. Collagen metabolism in
Brilla CG, Matsubara LS, Weber KT. Antifibrotic effects of spirono-
cipitating event. Increased left atrial volume is also an
lactone in preventing myocardial fibrosis in systemic arterial
hypertension. Am J Cardiol 1993;71:12A–16A.
HCM and was associated with more serious cardiovas-
cular events, greater diastolic dysfunction, and higher
cultured adult rat cardiac fibroblasts: response to angiotensin II
diastolic filling pressures (Yang et al. 2005). Negative
and aldosterone. J Mol Cell Cardiol 1994;26:809–820.
Brown NJ, Vaughan DE. Angiotensin-converting enzyme inhibitors.
prognostic indicators for early cardiovascular mortality
Circulation 1998;97:1411–1420.
in people with acute heart failure include hypotension,
renal impairment, hyponatremia, clinical congestion at Buchanan JW, Bucheler J. Vertebral scale system to measure canine
heart size in radiographs. J Am Vet Med Assoc 1995;206:194–199.
the time of discharge, increases in brain natriuretic Cannon RO, III, Rosing DR, Maron BJ, Leon MB, Bonow RO, Watson
peptide levels during therapy, and poor functional RM, et al. Myocardial ischemia in patients with hypertrophic car-
capacity at the time of discharge (Gheorghiade and Pang diomyopathy: Contribution of inadequate vasodilator reserve and
2009). elevated left ventricular filling pressures. Circulation 1985;71:
234–243.
REFERENCES Cheng V, Kazanagra R, Garcia A, Lenert L, Krishnaswamy P, Gardetto
N, et al. A rapid bedside test for B-type peptide predicts treatment
Boldface font indicates key references. outcomes in patients admitted for decompensated heart failure: A
Alboni P, Brignole M, Menozzi C, Scarfo S. Is sinus bradycardia a pilot study. J Am Coll Cardiol 2001;37:386–391.
factor facilitating overt heart failure? Eur Heart J 1999;20: Chennavasin P, Seiwell R, Brater DC. Pharmacokinetic-dynamic
252–255. analysis of the indomethacin-furosemide interaction in man. J
Aramaki Y, Uechi M, Takase K. Angiotensin converting enzyme and Pharmacol Exp Ther 1980;215:77–81.
chymase activity in the feline heart and serum. J Vet Med Sci Cicoira M, Zanolla L, Rossi A, Golia G, Franceschini L, Cabrini G, et
2003;65:1115–118. al. Failure of aldosterone suppression despite angiotensin-
Atkins CE, Gallo AM, Kurzman ID, Cowen P. Risk factors, clinical converting enzyme (ACE) inhibitor administration in chronic
signs, and survival in cats with a clinical diagnosis of idiopathic heart failure is associated with ACE DD genotype. J Am Coll
hypertrophic cardiomyopathy: 74 cases (1985–1989). J Am Vet Cardiol 2001;37:1808–1812.
Med Assoc 1992;201:613–618. Connolly DJ, Cannata J, Boswood A, Archer J, Groves EA, Neiger R.
Balcells E, Meng QC, Johnson WH, Jr., Oparil S, Dell’Italia LJ. Cardiac troponin I in cats with hypertrophic cardiomyopathy. J
Angiotensin II formation from ACE and chymase in human and Feline Med Surg 2003;5:209–216.
animal hearts: Methods and species considerations. Am J Physiol Connolly DJ, Magalhaes RJ, Syme HM, Boswood A, Fuentes VL, Chu
1997;273:H1769–H1774. L, et al. Circulating natriuretic peptides in cats with heart disease.
Bayne EJ, Williamson HE. Effect of furosemide on peripheral venous J Vet Intern Med 2008;22:96–105.
compliance following ureteral ligation in the adult dog. Res Cosin J, Diez J. Torasemide in chronic heart failure: Results of the
Commun Chem Pathol Pharmacol 1979;25:399–402. TORIC study. Eur J Heart Fail 2002;4:507–513.
The BENCH (BENazepril in Canine Heart disease) Study Group. The The COVE Study Group. Controlled clinical evaluation of enalapril
effect of benazepril on survival times and clinical signs of dogs in dogs with heart failure: results of the Cooperative Veterinary
with congestive heart failure: Results of a multicenter, prospective, Enalapril Study Group. The COVE Study Group. J Vet Intern Med
randomized, double-blinded, placebo-controlled, long-term clini- 1995;9:243–252.
cal trial. J Vet Cardiol 1999;1:7–18. Davies C, Forrester SD. Pleural effusion in cats: 82 cases (1987 to
Benigni L, Morgan N, Lamb CR. Radiographic appearance of car- 1995). J Small Anim Pract 1996;37:217–224.
diogenic pulmonary oedema in 23 cats. J Small Anim Pract de Berrazueta JR, Gonzalez JP, de Mier, I, Poveda JJ, Garcia-Unzueta
2009;50:9–14. MT. Vasodilatory action of loop diuretics: a plethysmography